Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Benchmark Maintains Buy on Lear, Raises Price Target to $170

Benchmark analyst Michael Ward maintains Lear (NYSE:LEA) with a Buy and raises the price target from $162 to $170.

byBenzinga Newsdesk

January 20, 2023

1 minute read

Benchmark analyst Michael Ward maintains Lear (NYSE:LEA) with a Buy and raises the price target from $162 to $170.

InflaRx Announces Phase III Topline Results From PANAMO Trial Of Vilobelimab In Severe COVID-19 Patients; Co. Reports Trial Did Not Show Statistical Significance On The Pre-specified Primary Endpoint

By Benzinga Newsdesk

Today, 6:03 PM

Vilobelimab treatment results in relative reduction in 28-day all-cause mortality of 23.9% compared to placebo (p-value=0.094), but did not show statistical significance on the pre-specified primary

IFRX

Why Zscaler Shares Are Rising Today

By Adam Eckert

Today, 6:03 PM

Zscaler Inc (NASDAQ: ZS) is trading higher Monday after multiple analyst firms maintained bullish ratings on the stock and raised their price targets, respectively.